SCHEMBL25419666

SCHEMBL25419666

O=C(c1ccccc1)N1CC=Cc2c1ccn1nccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.36
▸ HPGD P15428 2/20 0.36
▸ HTT P42858 1/20 0.33
▸ PSEN1 P49768 1/20 0.33
▸ PSEN2 P49810 1/20 0.33
▸ APH1B Q8WW43 1/20 0.33
▸ NCSTN Q92542 1/20 0.33
▸ APH1A Q96BI3 1/20 0.33
▸ PSENEN Q9NZ42 1/20 0.33
▸ P2RX4 Q99571 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ IDO1 P14902 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ RAB9A P51151 3/20 0.32
▸ TSHR P16473 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ AVPR2 P30518 1/20 0.32
▸ AVPR1A P37288 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25263722 0.73 RAB9A (0.46) ALDH1A1HPGDKMT2ARAB9ATSHR
SCHEMBL16736488 0.71 P2RX4 (0.43) ALDH1A1HPGDHTTPSEN1PSEN2
SCHEMBL8705933 0.69 P2RX4 (0.57) ALDH1A1HPGDHTTPSEN1PSEN2
SCHEMBL23496994 0.61 P2RX4 (0.45) ALDH1A1HPGDP2RX4KMT2ARAB9A
SCHEMBL6198860 0.60 P2RX4 (0.50) ALDH1A1HPGDHTTP2RX4MAPT
SCHEMBL705048 0.59 F2 (0.46) ALDH1A1HPGDP2RX4MAPTCYP1A2
SCHEMBL25270859 0.58 IDO1 (0.45) ALDH1A1HPGDMAPTIDO1CYP1A2
SCHEMBL3344788 0.57 PLA2G7 (0.61) ALDH1A1HPGDTSHRPOLBMAPK1
SCHEMBL13731712 0.57 HPGD (0.45) ALDH1A1HPGDP2RX4MAPTCYP2C19
SCHEMBL135362 0.57 ELANE (0.60) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250066318-A1 HETEROCYCLIC COMPOUNDS AS DYRK1A INHIBITORS PROTHENA BIOSCIENCES INC 2025-02-27 — — US disclosed
CN-118843626-A Heterocyclic compounds as DYRK1A inhibitors 普罗塞纳生物科学有限公司 2024-10-25 — — CN disclosed
EP-4444421-A2 HETEROCYCLIC COMPOUNDS AS DYRK1A INHIBITORS Prothena Biosciences Limited (IE) 2024-10-16 — — EP disclosed
WO-2023107714-A2 METHODS FOR TREATING NEUROLOGICAL DISORDERS PROTHENA BIOSCIENCES LIMITED (IE) 2023-06-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250066318-A1 HETEROCYCLIC COMPOUNDS AS DYRK1A INHIBITORS DYRK1A, DYRK2, DYRK1B ALDH1A1 3352/4885HPGD 3062/4885HTT 257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback